Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.

Clinical and translational allergy·2017
Same author

Work productivity in rhinitis using cell phones: The MASK pilot study.

Allergy·2017
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.

Allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same author

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

The journal of nutrition, health & aging·2016
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

Red wine asthma: a controlled challenge study.

R Dahl, J M Henriksen, H Harving

    The Journal of Allergy and Clinical Immunology
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Sulfur dioxide (SO2) in red wine can trigger asthma symptoms like bronchospasm. This study found high SO2 levels were most likely to cause severe reactions in sensitive individuals, suggesting labeling is needed.

    More Related Videos

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
    01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Published on: June 19, 2025

    277
    Pulmonary Embolism I: Introduction
    01:29

    Pulmonary Embolism I: Introduction

    Published on: June 19, 2025

    464

    Related Experiment Videos

    Last Updated: Jan 9, 2026

    Pulmonary Embolism III: Nursing Management
    01:27

    Pulmonary Embolism III: Nursing Management

    Published on: June 19, 2025

    320
    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
    01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Published on: June 19, 2025

    277
    Pulmonary Embolism I: Introduction
    01:29

    Pulmonary Embolism I: Introduction

    Published on: June 19, 2025

    464

    Area of Science:

    • Allergy and Immunology
    • Pulmonology
    • Food Science

    Background:

    • Asthma patients may experience bronchospasm when drinking red wine.
    • Identifying specific triggers in red wine is crucial for managing asthma symptoms.

    Purpose of the Study:

    • To investigate the role of sulfur dioxide (SO2) and amines in red wine-induced asthma.
    • To determine the primary causative agent in red wine that provokes asthmatic reactions.

    Main Methods:

    • A double-blind study involving 18 asthma patients with a history of red wine reactions.
    • Patients were challenged with red wine varying in SO2 and amine content.
    • Reactions were monitored by measuring peak expiratory flow (PEF).

    Main Results:

    • Nine out of 18 subjects showed significant bronchospasm.
    • The most severe reactions occurred consistently after consuming red wine with high SO2 content.
    • Amine content did not appear to be the primary trigger.

    Conclusions:

    • Sulfur dioxide (SO2) is identified as the most significant factor in red wine-induced asthma.
    • Recommendations are made for wine producers to disclose SO2 content on labels.
    • Further research may explore individual sensitivities to wine components.